The integration of targeted agents into systemic therapy of metastatic colorectal cancer.
Arnold
D
D
Haematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Siewczynski
R
R
Schmoll
H-J
HJ
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A